SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-178026
Filing Date
2017-05-22
Accepted
2017-05-22 16:07:32
Documents
2
Group Members
VIFOR (INTERNATIONAL) LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d350957dsc13d.htm SC 13D 52169
2 EX-99.1 d350957dex991.htm EX-99.1 5717
  Complete submission text file 0001193125-17-178026.txt   59468
Mailing Address UNTERMATTWEG 8 BERNE V8 CH-3027
Business Address UNTERMATTWEG 8 BERNE V8 CH-3027 41 58 852 81 11
Vifor Pharma Ltd. (Filed by) CIK: 0001416422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88058 | Film No.: 17860969
SIC: 2834 Pharmaceutical Preparations